Showing results (521-530 of 687) with videos related to
Sort By:
Pageof 69
European Journal of Paediatric Dentistry|December 19, 2019
Prevalence and determinants of early childhood caries in ItalyS Colombo, S Gallus, M Beretta, et al.The Journal of Experimental Medicine|October 22, 2003
Lipopolysaccharide or whole bacteria block the conversion of inflammatory monocytes into dendritic cells in vivoGianluca Rotta, Emmerson W Edwards, Sabina Sangaletti, et al.European Journal of Cell Biology|May 1, 1995
Ultrastructural, immunocytochemical and stereological investigation of hepatocytes in a patient with the mutation of the ornithine transcarbamylase geneK P Zimmer, I Matsuda, T Matsuura, et al.Natural Immunity|March 1, 1994
Nature and potential of the reactive response to mouse mammary adenocarcinoma cells engineered with interleukin-2, interleukin-4 or interferon-gamma genesP Musiani, A Modesti, M Brunetti, et al.Langmuir : the ACS Journal of Surfaces and Colloids|September 26, 2008
Structure of self-organized multilayer nanoparticles for drug deliveryY Gerelli, S Barbieri, M T Di Bari, et al.Cancer Research|December 6, 2006
p50 nuclear factor-kappaB overexpression in tumor-associated macrophages inhibits M1 inflammatory responses and antitumor resistanceAlessandra Saccani, Tiziana Schioppa, Chiara Porta, et al.Plos One|February 27, 2013
Neoplastic and stromal cells contribute to an extracellular matrix gene expression profile defining a breast cancer subtype likely to progressTiziana Triulzi, Patrizia Casalini, Marco Sandri, et al.Revista Argentina De Microbiologia|July 24, 2013
Differential effects of two strains of Rhizophagus intraradices on dry biomass and essential oil yield and composition in Calamintha nepetaRoxana P Colombo, Alicia Martínez, Agustina Fernández di Pardo, et al.Transplant International : Official Journal of the European Society for Organ Transplantation|July 17, 1998
Assessment of troponin-T for detection of clinical cardiac rejectionB H Walpoth, B Celik, G Printzen, et al.Cancer Research|December 1, 1994
Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with interleukin (IL)-2, IL-4, IL-6, IL-7, IL-10, tumor necrosis factor alpha, granulocyte-macrophage colony-stimulating factor, and gamma-interferon gene or admixed with conventional adjuvantsA Allione, M Consalvo, P Nanni, et al.Pageof 69